Rahul Mohindar of viratechindia.com told CNBC-TV18, "Ipca Laboratories is in momentum in a tough market like today, we still think that there is good potential here. The level of Rs 800 in the last 6-9 months has been a very big block hole for the stock. So, we will at least move to Rs 800-805 level. But, in the longer-term, I like Ipca Laboratories for a target of about Rs 920. So, if you are a long-term investor, certainly a stock to keep on the radar."At 14:53 hrs Ipca Laboratories was quoting at Rs 766.65, up Rs 4.65, or 0.61 percent. It has touched an intraday high of Rs 781.05 and an intraday low of Rs 749.40.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!